4//SEC Filing
FORD KATHLEEN 4
Accession 0001209191-21-021320
CIK 0001422143other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:17 PM ET
Size
9.2 KB
Accession
0001209191-21-021320
Insider Transaction Report
Form 4
FORD KATHLEEN
Chief Operating Officer
Transactions
- Exercise/Conversion
Option to purchase common stock
2021-03-15−6,250→ 215,625 totalExercise: $19.43Exp: 2029-08-08→ Common Stock (6,250 underlying) - Sale
Common Stock
2021-03-15$29.43/sh−6,250$183,951→ 0 total - Exercise/Conversion
Common Stock
2021-03-15$19.43/sh+6,250$121,438→ 6,250 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2020.
- [F2]This transaction was executed in multiple trades at prices ranging from $29.43 to $29.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This option vests in 48 equal monthly installments commencing on August 9, 2019.
Documents
Issuer
Kura Oncology, Inc.
CIK 0001422143
Entity typeother
Related Parties
1- filerCIK 0001785406
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:17 PM ET
- Size
- 9.2 KB